Özet:

Purpose: assessment of the technical and oncological outcomes of our first 56 patients with robotic-assisted partial nefrectomy (RYPN) due to kidney tumor in our clinic. Materials and methods: Data collected prospectively from 56 patients in RYPN between March 2015 and February 2018 were reverse analysis. Preoperative blood parameters were examined with hemoglobin, serum urine/creatine and liver function tests. Perioperative parameters; blood transfusions were recorded with the periods of surgery and skemic. Postoperatively hemoglobin values and pathological results were studied. Results: RYPN was applied with transperitoneal approach to 44 men and 12 women with an average age of 59 (32-84) years. The average tumor diameter is 3.8 cm (1. The 5-8) 27 right, 29 left renal units were operated. The average operation time was 151 minutes (90-250), the average heat time ischemic was 24.5 minutes (18-35), the average blood loss was 63 ml (25-100). Perirenal hematoma, which requires transfusion, was observed in a patient (1.7%). None of the patients had no need to go back to open surgery, and none of the patients had no need for nefrectomy. In eight patients, the pelvicalyctic system was repaired because it was opened, but no one needed to place a genital stent. 78.5% of the kidney masses were as primary renal cell carcinoma and in 4 patients (9.0%) the surgical limit was indicated as positive. The average follow-up period of patients was 13(4-36) months and no local recurrent or distant metastases were observed in any patient. There were no late period complications observed in any patient, such as insuficient herni. RYPN is a surgical method that can be safely applied to well-selected stage 1 kidney tumors. Thanks to the ease of throwing and freedom of movement provided by the surgeon, it keeps the time of hot scem at reasonable levels, ensuring that the expected oncological and functional results are achieved with low morbidity.

Anahtar Kelimeler: